Search results

34 items
  1. What comes next? Post-UNGASS options for 2019-2020

    • International Drug Policy Consortium (IDPC)
    29 November 2016

    The UN General Assembly Special Session (UNGASS) on drugs – held in New York in April 2016 – was hailed as an opportunity for the international community ‘to conduct a wide-ranging and open debate that considers all options’. Although the UNGASS was characterised by many shortcomings and disappointments, it was nonetheless a critical moment for global drug policy reform.

  2. UNGASS 2016: A Broken or B-r-o-a-d Consensus?

    • David Bewley-Taylor, Martin Jelsma
    05 July 2016
    Policy briefing

    A special session of the General Assembly took place in April revealing a growing divergence in the global drug policy landscape. Difficult negotiations resulted in a disappointing outcome document, perpetuating a siloed approach to drugs at the UN level. There is a clear need to realign international drug policies with the overarching 2030 Agenda and the Sustainable Development Goals, embedding the drugs issue comprehensively within the UN’s three pillars: development, human rights, and peace and security. The UNGASS process has helped to set the stage for more substantial changes in the near future, towards the next UN review in 2019.

  3. UNGASS 2016: Background memo on the proposal to establish an expert advisory group

    08 December 2015
    Policy issue

    Several countries have recently expressed support for the idea to use the mechanism of an expert advisory group again for the UNGASS in 2016

  4. IDPC recommendations for the "ZERO DRAFT" of the UNGASS outcome document

    • International Drug Policy Consortium (IDPC)
    22 July 2015

    Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.

  5. International Law and Drug Policy Reform

    16 July 2015

    Drug policy reform is currently higher on the international agenda than it has been in recent memory. With a United Nations General Assembly Special Session (UNGASS) on drugs set for 19-21 April 2016, the prominence of this issue will further increase. Significant legal and policy reforms at the national level have taken place in recent years that pose considerable challenges to the international legal framework for drug control, and beg important questions regarding states’ international legal obligations.

  6. Prospects for Treaty Reform and UN Coherence on Drug Policy

    • Martin Jelsma
    01 May 2015
    Policy briefing

    Can UNGASS 2016 realistically initiate a process of modernizing the global drug control system and breathe oxygen into a system risking asphyxiation?

  7. The Current State of Counternarcotics Policy and Drug Reform Debates in Myanmar

    • Tom Kramer
    01 May 2015
    Report

    Are Myanmar's current drug policies effective? How do they impact important issues such as human rights, sustainable development, ethnic conflict, and the peace process?

  8. Improving global drug policy: Comparative perspectives and UNGASS 2016

    • Vanda Felbab-Brown, Harold Trinkunas (eds)
    28 April 2015

    As the world prepares for the 2016 Special Session of the United Nations General Assembly on the World Drug Problem (UNGASS 2016), an increasing number of countries around the world now find the regime’s emphasis on punitive approaches to illicit drugs to be problematic and are asking for reform. In this moment of global disagreement, the Brookings project on Improving Global Drug Policy provides a unique comparative evaluation of the effectiveness and costs of international counternarcotics policies and best approaches to reform.

  9. The Road to UNGASS 2016

    • International Drug Policy Consortium (IDPC)
    14 April 2015

    On 19th to 21st April 2016, there will be a United Nations General Assembly Special Session (UNGASS) held in New York, dedicated to the issue of drug policy. The General Assembly is the highest policy making and representative organ of the United Nations (UN), and its infrequent Special Sessions focus on pertinent topics at the request of member states. The UNGASS on drugs has the potential to be a ground-breaking, open debate about the international drug control system – but there is much work to be done to ensure that it fulfils that potential.

  10. The International Drug Control Regime and Access to Controlled Medicines

    • Christopher Hallam
    28 December 2014
    Policy briefing

    In poor and developing nations pain remains largely uncontrolled. Africa is the least well served continent for access to analgesia.

  11. Scheduling in the international drug control system

    • David Bewley-Taylor, Martin Jelsma, Christopher Hallam
    16 June 2014
    Policy briefing

    Scheduling is mostly prioritised in its repressive pole, though present debates are increasingly highlighting the need to modify the balance of the system in order to affirm the importance of the principle of health.

  12. UNODC’s shifting position on drug policy: Progress and challenges

    • International Drug Policy Consortium (IDPC)
    31 January 2014
    Policy issue

    In March 2014, country delegations will gather at the United Nations Commission on Narcotic Drugs (CND) to review progress and challenges in international drug control since the agreement of a Political Declaration on drugs in 2009. Given that the Political Declaration aims to “eliminate or reduce significantly” the use, supply and demand of controlled drugs by 2019, this meeting represents an important opportunity for honest evaluation and an acknowledgement that these targets are not being achieved. With a United Nations General Assembly Special Session (UNGASS) on drugs just two years away, this is an important time for international drug control policy.

  13. Governing The Global Drug Wars

    23 October 2012
    Report

    Since 1909 the international community has worked to eradicate the abuse of narcotics. A century on, the efforts are widely acknowledged to have failed, and worse, have spurred black market violence and human rights abuses. How did this drug control system arise, why has it proven so durable in the face of failure, and is there hope for reform?

  14. Fact Sheet: Coca leaf and the UN Drugs Conventions

    02 October 2012
    Primer

    10 Facts about the Coca leaf and the UN Drugs Conventions in chronological order

             
  15. Image of UN Flag

    Why is the outcome of the United Nations drug policy review so weak and inconclusive?

    31 March 2009

    Political representatives from over 130 countries gathered at a United Nations high level meeting in Vienna on March 11-12, 2009, to conclude a 2-year long review of progress achieved within the global drug control system. Despite calls from other UN agencies and international civil society urging the CND to affirm its support for harm reduction measures, and to rebalance the drug control system towards a public health and human rights approach, the new Political Declaration simply reaffirms the commitments of the 1998 UNGASS - repeating illusionary pledges for a society 'free of drug abuse' and setting another 10-year target date to eliminate or reduce significantly the illicit cultivation of opium poppy, coca bush and cannabis plant. This briefing paper examines the procedural and institutional factors that we believe have contributed to such a weak and incoherent outcome.

     

  16. Global Illicit Drug Markets 1998-2007

    • Peter Reuter (RAND), Franz Trautmann (Trimbos Institute) (eds.)
    15 March 2009
    Report

    This report commissioned by the European Commission, found no evidence that the global drug problem has been reduced during the period from 1998 to 2007 – the primary target of the 1998 UNGASS, which aimed to significantly reduce the global illicit drugs problem by 2008 through international cooperation and measures in the field of drug supply and drug demand reduction. Broadly speaking the situation has improved a little in some of the richer countries, while for others it worsened, and for some of those it worsened sharply and substantially', among which are a few large developing or transitional countries. Given the limitations of the data, a fair judgment is that the problem became somewhat more severe.

  17. Alternative development should be unconditional

    • Martin Jelsma
    12 March 2009

    Martin Jelsma of TNI expressed the disappointment with the agreed texts on alternative development in the Political Declaration and Plan of Action at the Commission on Narcotic Drugs (CND) dedicated to the 1998 UNGASS review. No consensus could be reached on the issue of drug control conditionality in development assistance, despite the outcomes of expert evaluations that recommended to "not make development assistance conditional on reductions in illicit drug crop cultivation”, and to "ensure that eradication is not undertaken until small-farmer households have adopted viable and sustainable livelihoods and that interventions are properly sequenced."

    He further referred to the outcomes of the first World Forum of farmers of coca, cannabis and opium poppy from Latin America, Africa and Asia.

    Read the full statement (PDF)

  18. Image of UN Flag

    Coherence Not Denial

    09 March 2009

    As the international community finalises the Political Declaration and work plan that will guide the next ten years of international drug policy, it is inconceivable and indeed unconscionable that support for scientifically proven, evidence-based harm reduction programmes will again be blocked. States must show responsible leadership and act in the best interests of public health and human rights, rather than the narrow and failed language of ‘a drug free world’. This issue is much bigger than ideology, semantics and intergovernmental wordplay. It is about saving lives.

     

  19. International Drug Policy: Animated Report 2009

    05 March 2009

    Produced by an Oscar-winning studio for the Global Drug Policy Program of the Open Society Institute, International Drug Policy: Animated Report 2009 highlights some of the disastrous effects of drug policy in recent years and proposes solutions for a way forward.

  20. International Support for Harm Reduction

    20 January 2009

    A useful overview of UN endorsement of harm reduction measures; the legality of harm reduction services under the Drug Conventions; the obligation in human rights law to ensure access to harm reduction services and the global state of harm reduction, listing 82 countries and territories worldwide that presently support or tolerate harm reduction.

     

Pages